What are the goals of the FDA’s Drug Competition Action Plan?


According to the Food and Drug Administration (FDA), the Drug Competition Action Plan (DCAP) has the goals of:

  • “Improving the efficiency of generic drug development, review, and approval processes
  • Maximizing scientific and regulatory clarity with respect to generic drugs for complex products
  • And closing loopholes that allow brand drug companies to “game” the system in ways that thwart generic competition.”


CPT® copyright 2021 American Medical Association (AMA). All rights reserved.

Fee schedules, relative value units, conversion factors and/or related components are not assigned by the AMA, are not part of CPT, and the AMA is not recommending their use. The AMA does not directly or indirectly practice medicine or dispense medical services. The AMA assumes no liability for data contained or not contained herein.

CPT is a registered trademark of the American Medical Association.